GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Regulated » Aquaporin AS (FRA:00B) » Definitions » ROCE %

Aquaporin AS (FRA:00B) ROCE % : -31.17% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aquaporin AS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aquaporin AS's annualized ROCE % for the quarter that ended in Jun. 2024 was -31.17%.


Aquaporin AS ROCE % Historical Data

The historical data trend for Aquaporin AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquaporin AS ROCE % Chart

Aquaporin AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -33.08 -38.35 -54.42 -40.26 -40.00

Aquaporin AS Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.36 -48.08 -36.40 -42.52 -31.17

Aquaporin AS ROCE % Calculation

Aquaporin AS's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-12.593/( ( (36.366 - 3.277) + (35.227 - 5.345) )/ 2 )
=-12.593/( (33.089+29.882)/ 2 )
=-12.593/31.4855
=-40.00 %

Aquaporin AS's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=-11.582/( ( (35.227 - 5.345) + (48.233 - 3.795) )/ 2 )
=-11.582/( ( 29.882 + 44.438 )/ 2 )
=-11.582/37.16
=-31.17 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aquaporin AS  (FRA:00B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Aquaporin AS ROCE % Related Terms

Thank you for viewing the detailed overview of Aquaporin AS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aquaporin AS Business Description

Traded in Other Exchanges
Address
Nymollevej 78, Kongens Lyngby, DNK, DK-2800
Aquaporin AS is a water technology company dedicated to rethinking water filtration with biotechnology. Its products include Clear Eco, Clear Ultra, Clear Plus, Clear Plus FR, and Clear Classic. The company operates geographically in four markets; EMEA, APAC, and Americas, out of which it derives a majority of its revenue from the APAC market.

Aquaporin AS Headlines

No Headlines